ACHL

ACHL


A Closer Look at PAH Diagnosis, Screening, and Risk Assessment

In this short “How I Do It” vlog, expert faculty Dr. John Ryan, Director, Pulmonary Hypertension Comprehensive Care Center, University of Utah Hospital showcases personal experiences incorporating updated recommendations in clinical practice as well as diagnostic approaches, screening methods, and the importance of risk assessment. Upon completion of this activity, clinicians will be better ...
ACHL

A Step in the Right Direction: Updates for Your PAD Patients Post-Revascularization

For your patients with PAD post-revascularization, what can you do to ensure the next “steps in the right direction”? In this activity, expert faculty cover the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. Roundtable discussion is included to provide practical insight for clinicians to apply knowledge to their practice.
ACHL

Are We There Yet? Strategies to Employ JAK Inhibitors in T2T for RA

Are you effectively employing treat-to-target strategies into your daily practice? Data from the Corrona RA registry tell a different story: a large number of patients with RA still had moderate or high levels of disease activity after 6 and 12 months of csDMARD and/or bDMARD therapy, with no acceleration of treatment. Dr. Allan Gibofsky, Co-Director, Clinic for Inflammatory Arthritis and Biolog...
ACHL

Breakthroughs for Obese Patients with VTE

What is the latest evidence for VTE prophylaxis and treatment in obese patients and how is this different from the current guidelines? In this activity, expert cardiology faculty cover the most recent data and guideline limitations on VTE prevention and management. Roundtable discussion is included to provide practical insight to help clinicians apply knowledge to their practice.
ACHL

Change the Story: Preventing Missteps With Invasive Fungal Infections

Have you ever wondered what went wrong in the management of invasive fungal infections? Through a storytelling approach Dr. Lewis & Dr. Thompson will discuss a clinical story and identify where medical misses may have occurred. Supportive evidence will be provided on how care should have been provided and strategies for clinicians to apply in their practice.
ACHL

Closing in on Post-Thrombotic Syndrome: The Latest Updates

Dr. Kush Desai from Northwestern Medicine and Dr. Erin Murphy from Sanger Heart and Vascular, Atrium Health discuss the latest updates in post-thrombotic syndrome (PTS) including a review on the newer venous stents as well as limitations with conservative therapies in this targeted 30-minute CME eNewsletter. The touchpoint also features images, easy-to-read charts and graphs and feature their ex...
ACHL

Complex Chronic Deep Venous Disease: A Multidisciplinary Discussion

Are you confident with managing cases of complex chronic deep venous disease? This 30-minute roundtable discussion, features leading venous disease experts, Minhaj Khaja, MD, MBA, FSIR from University of Virginia; Andrea Obi, MD from University of Michigan; and Aditya Sharma, MD, from University of Virginia who highlight complex cases related to chronic deep venous disease. Faculty discuss the l...
ACHL

Considerations for Antimicrobial Selection in Clostridioides difficile Infection

This educational program is designed for infectious disease pharmacists interested in new therapies and clinical trials in the treatment of CDI. Dr. Paul Feuerstadt and Dr. Kevin Garey discuss community and healthcare-associated infections, recent updates to guidelines, and evidence-based selection of antimicrobial therapy for the treatment of initial infection and prevention of recurrence. W...
ACHL

COVID-19 and Rheumatology Care: How Does it Impact My Patients?

Already facing unprecedented changes in approaches to patient care, rheumatology practices must now navigate the unfamiliar landscape of COVID-19 and translate rapidly evolving evidence into routine clinical practice. And while every day brings new data and guidance on best practices for managing rheumatology patients during a pandemic, it is often the perspectives of our colleagues in the field...
ACHL

Decisions in Interventional Management of Acute Pulmonary Embolism

Clinicians who diagnose and treat patients with acute pulmonary embolism (PE) need to be updated on guidelines and trials regarding the current interventional therapeutic landscape, particularly with catheter-directed devices. In this targeted 30-minute CME touchpoint, Dr. Adrian Messerli from UK HealthCare discusses the latest recommendations for the management of PE. This interactive activity...
ACHL

DOACs in Transition: Examining the Challenges and Complexity of Transitions in Care

Why should hospitalists, cardiologists, and other clinicians care about optimal post-discharge prophylaxis in patients with acute medical illness? What strategies are available to better ensure optimal post-discharge prophylaxis in this patient population? This clinical commentary features leading thrombosis expert, Dr. Alex Spyropoulos, and a multidisciplinary panel, covering these important qu...
ACHL

Final Chapter: Post-COVID-19 Fibrosis and the Role of Antifibrotic Therapy Management

What do we know about post-ARDS fibrosis in patients who have recovered from COVID-19? In this 8-minute CME-certified vlog, leading pulmonology expert Christopher King, MD, FACP, FCCP, Director of Transplant and Advanced Lung Disease Critical Care Program at Inova Fairfax Hospital, will discuss topics such as: • post-ARDS fibrosis in patients who have recovered from COVID-19 • the potentia...
ACHL

From Risk Assessment to Treatment: Real-World Approaches to PAH

In this clinical commentary, join cardiology expert Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan and pulmonology expert Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center as they provide real-world advice on the management of pulmonary arterial hypertension (PAH). These experts will discuss thei...
ACHL

Hard to Swallow: Bridging Knowledge Gaps in Eosinophilic Esophagitis

Did you know that the incidence of eosinophilic esophagitis (EoE) is increasing rapidly? Are you familiar with the burdens faced by adult and pediatric patients living with EoE? In this multi-module activity led by an interdisciplinary panel, access practical guidance and supplemental resources on the management and treatment of EoE. Navigate at your own pace through video modules and an interac...
ACHL

Highlights from Kidney Week

Expert faculty, Dr. Jai Radhakrishnan explores clinical trial data coming out of ASN 2021, and provides learners with up-to-date knowledge on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). This brief interview-style video offers insights into the patient burden of chronic kidney disease, advances in understanding the pathophysiology, and emerging approaches to treatment fo...
ACHL

Highlights from the 12th Annual Linda Morgante MS Nurse Leadership Program

This enduring activity features three presentations from the 12th Annual Linda Morgante MS Nurse Leadership Program held virtually on June 26, 2021. These presentations will provide multiple sclerosis (MS) nurses access to the latest evidence and strategies related to treatment selection, treat-to-target approaches, and symptom management as part of comprehensive patient care to improve outcomes.
ACHL

Hindsight is 2020: COVID-19 and Cancer Care

As the global COVID-19 pandemic enters its second year, advances in preventive measures and treatment approaches are now benefiting patients dealing with cancer. In turn, clinicians, cancer patients, and clinical practice have evolved to continue life-saving treatment. Mia Levy, MD, PhD, System Vice President for Cancer Services at Rush System for Health, leads a discussion with Rush Universi...
ACHL

Hot Topics in Oncology – Focus on the Immune Checkpoint Inhibitors (ICIs)

The immune checkpoint inhibitors (ICIs) continue to break ground in a multitude of cancer types. With ever-evolving data and recommendations, oncology clinicians must keep pace with the latest ICI updates. This recorded CME-certified session tackles questions surrounding topics related to immune checkpoint inhibitors with discussion on: • Role of biomarkers with ICI selection and monitorin...
ACHL

Hot Topics in PAH: What We’ve Learned in the Past Year

How can clinicians improve early detection of PAH? What are some practical strategies for managing PAH patients in today’s world? What recent data support current treatment strategies, and what are emerging therapeutic options? This 30-minute multimedia Q&A touchpoint “Hot Topics” CME activity features leading pulmonology expert Dan Schuller, MD, from Texas Tech University Health Sciences ...
ACHL

Improving Outcomes in Chronic Limb-threatening Ischemia: Practical Approaches to Above- and Below-the-knee Interventions

In this targeted 45-minute CME touchpoint, Dr. Anahita Dua, vascular surgeon from Massachusetts General Hospital, and Dr. Mitchell Weinberg from Staten Island University Hospital and Zucker School of Medicine at Hofstra/Northwell, discuss the latest updates in approaches to above-the-knee and below-the-knee interventions for chronic limb-threatening ischemia (CLTI). The faculty will also address...
ACHL

Improving Outcomes in CTD-PAH: Diagnosis, Treatment & Multidisciplinary Care

In this interview-style eNewsletter, Dr. Dinesh Khanna and Dr. Victor Tapson share ways to improve the recognition and diagnosis of CTD-PAH. Through discussions on the role of screening and a review of current and emerging therapies, our faculty provide context to creating a personalized treatment approach that highlights the importance of increasing communication across a multidisciplinary team...
Purdue University College of Pharmacy

Improving the Prognosis for Patients with BRAF-Mutant and/or MSI-H mCRC

Are you current with the latest updates with MSI-H/dMMR and/or BRAF-mutant metastatic colorectal cancer? In this case-based activity, leading expert and researcher, Dr. Dung Le discusses the latest approvals and recommendations for patients with MSI-H/dMMR and/or BRAF-mutant mCRC. This activity also features interactive case presentations which involve biomarker testing, treatment selection, and...
ACHL

In Limb-O: Improving CAD and PAD Care in the Stably Unstable

Unprotected, your patients with CAD and PAD are on the edge, in “limb-o” – how do we get them to become more in balance? In this activity, expert multidisciplinary faculty cover the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. A patient case is woven throughout this discussion to increase opportunities for clinicians...
ACHL

It’s Getting Hot in Here: The Unaddressed Problems of Vasomotor Symptoms During Menopause

In three brief video segments, expert faculty provide practical guidance for managing and treating vasomotor symptoms in menopausal women. Discussion covers gaps in care, guideline recommendations, a novel mechanism for controlling vasomotor symptoms, and strategies to communicate with patients. Hear first-hand testimonials from patients to learn more about how vasomotor symptoms impact their qu...
ACHL

Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer

Join the discussion! We bring the expert to you. LIVE. VIRTUAL. FLEXIBLE. Interactive discussion on optimization of RET+ testing in NSCLC and thyroid cancer, and the pathways for enhancing collaboration between pathologists and oncologists to improve patient care. Choose a date that works best with your schedule! Your questions answered on precision medicine! - What are the roles of biomar...
ACHL

Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer

This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the treatment of patients with prostate cancer. Faculty provide practical guidance to apply available and emerging data in real-world decision-making that clinicians are faced with on a daily basis including: interpreting results to inform treatment decisions, b...
ACHL

New Horizons in Pustular Psoriasis: Will You Be Ready? CME Virtual Meet-Up’s Highlights

Clinicians must be ready to translate rapidly evolving guidance and emerging science to improve outcomes for their patients. Dr. Mark Lebwohl from the Icahn School of Medicine at Mount Sinai recently hosted several small-group CME Meet-Up’s. This recorded meet-up discusses: - the lack of U.S. guidance that complicates diagnosis and disease assessment - the most recent pathophysiologic findi...
ACHL

On a Limb: How Can We Better Optimize PAD Care?

Are your patients with PAD post-revascularization “on a limb”? Find out as Marc Bonaca, MD, MPH covers the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. This expert perspective provides clinicians with practical insights to apply to their practice. The purpose of this activity is to provide learners with an engaging,...
ACHL

Optimizing Medical Management Post-Revascularization: A Case Review

In this activity, expert faculty give their multidisciplinary perspectives in vascular surgery and cardiology regarding recommendations for patients with peripheral artery disease (PAD) post-revascularization. These patients are at risk for further complications and may be eligible for additional therapy. Dr. Marc Bonaca and Dr. Alan Dietzek relay practice implications of the latest guidelines a...
ACHL

Oral Combination Therapy: The PAtH to Improved Patient Care in PAH

Are you interested in finding out how you can more effectively manage your patients with PAH? In this short “How I Do It” vlog, expert faculty Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan discusses recommendations for the use of oral combination therapies in PAH along with her experiences and considerations with these treatment options...
ACHL

PAH and COVID-19: A Patient’s Journey

PAH patient and advocate, Jen C., shares her perspective, experience, and challenges with managing her PAH every day and during her COVID-19 infection. Learn from her journey and consider how her experiences may improve your own PAH patients’ outcomes.
ACHL

PAH Patients and the Pandemic: Reducing Risk and Impact

Has the pandemic impacted your patients with PAH? Have you changed your care of these patients? In this short CME-certified vlog, leading pulmonologist Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, discusses how the pandemic has impacted his patients and reviews available evidence on reducing risks in PAH patients during the pandemic. He also to...
ACHL

Postdischarge Thromboprophylaxis for Acutely Ill Medical Patients

Did you know that hospitalized acutely ill medical patients remain at risk for venous thromboembolism (VTE) well past the time of discharge? In this short vlog, learn how to identify risk factors and avoid this complication as Dr. Mark Goldin shares a hospitalist’s perspective on the latest updates on postdischarge VTE prophylaxis for acutely ill medical patients. Dr. Goldin also discusses inn...
ACHL

Practical Considerations for Patients with PAD Post-Revascularization

This vlog provides learners with the perspective of a leading vascular medicine expert, Dr. Anahita Dua, on recent advances and practical considerations for patients with PAD post-revascularization. Talking points include the latest approvals and evidence, real-world implications of these recent advances, and roles of the interdisciplinary team in the management of this patient population. Th...
ACHL

Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2

Host a complimentary Virtual Visiting Professorship Program (VPP): Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2. Easy-to-administer one-hour complimentary virtual independent medical education is available to your institution. We will coordinate a day and time that works for your intuition and bring the expert to ...
ACHL

Prevent the Downward Spiral: Restoring the Gut Microbiota to Reduce Recurrent C. difficile Infection

Are we waiting too long? It’s time to get off this ride to avoid the downward spiral of recurrent C. difficile. Paul Feuerstadt, MD, Teena Chopra, MD and Kevin Garey, PharmD, discuss the gut microbiota role, management of C. difficile infection in special populations, safety and efficacy of fecal microbiota transplantation, and emerging microbiota restoration therapies.
ACHL

RCC Treatment Strategies in a Favorable-Risk Patient

Immune checkpoint inhibitor/tyrosine kinase inhibitor combination therapy has forged to the front-line for the management of metastatic RCC and recurrent RCC, but how do clinicians select the ideal treatment regimen for their patients? How does patient risk status influence the decision-making process? This virtual tumor board features a multidisciplinary expert panel presenting a favorable-risk...
ACHL

RCC Treatment Strategies in a Poor-Risk Patient

Did you know that the current 5-year survival rate for patients diagnosed with metastatic RCC is only 12% despite advances in molecular research over the past decade? Are you familiar with recent treatment guidelines and clinical trial data showcasing the benefits of treating poor- and intermediate-risk ccRCC patients with immuno-oncology/tyrosine kinase inhibitor combination therapy? This virtu...
ACHL

Real-World Perspectives on the Role of TYK2 Inhibitors in the Treatment of Psoriasis

How are TYK2 inhibitors different from conventional JAK inhibitors? In what patient population would they be best suited? Find out in this expert-led clinical review and panel discussion that provides the knowledge you need on the investigational TYK2 inhibitors and their potential roles in personalized psoriasis treatment plans. This content is available across two modules, allowing you to cho...
ACHL

Reducing Healthcare Disparities for PAH Patients

Very few studies have assessed the impact of healthcare disparities on PAH, despite the potential adverse impacts. One such study from Talwar et al reported that minority PAH patients may be at risk for worse outcomes due to lack of healthcare access, insurance gaps, and socioeconomic status. Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, draws f...
ACHL

Treatment Considerations for PAH Patients During the Pandemic

Are you taking the right precautions to ensure your patients with PAH are safely managed during COVID-19? Are you employing effective therapeutic management strategies with your PAH patients during the pandemic? In this short CME-certified vlog, leading pulmonologist Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, discusses how to effectively mana...
ACHL

Tryptase Testing: Clinical Utility and Application During COVID-19 Vaccination Reactions

What is the risk of anaphylaxis following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19)? Are you familiar with the role of serum tryptase testing in patients with a suspected anaphylactic reaction? Expert faculty, Dr. Cem Akin, discusses serum tryptase testing and its importance in assessing anaphylaxis in response to COVID-19 vaccination. This moder...
ACHL

VTE Prophylaxis in Acutely Ill Medical Patients

What is the latest evidence for VTE prophylaxis in acutely ill medical patients and how is this different from the current guidelines? In this activity, expert cardiology faculty cover the most recent data and guideline limitations on VTE prevention in this key patient group. Roundtable discussion is included to provide practical insight to help clinicians apply knowledge to their practice.
ACHL

What Every Clinician Needs to Know About COVID-19 and Thrombosis

As the COVID-19 pandemic continues to wage on, are you prepared to prevent and treat your patients for COVID-19-related venous thromboembolism (VTE)? In this short vlog, learn how to develop appropriate regimens with antithrombotic therapy for this patient population and hear about the promising PREVENT-HD trial. Leading VTE expert, Dr. Gregory Piazza, outlines key real-world insights that you ...
ACHL

Who’s On The Tightrope? Understanding Patients With Chronic Polyvascular Disease

Many atherosclerotic cardiovascular disease (ASCVD) patients do well after suffering a heart attack or stroke, but frequently, these patients continue to be at high risk for recurrent cardiovascular events and are not necessarily stable. It is important to understand the patients, particularly those with polyvascular disease, at higher risk for recurrent events. Are you current with how to best ...
ACHL

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map